Coastal Valleys EMS Agency News
2016 Field Treatment Guideline Change
The following treatment guideline has been revised and is effective immediately:
Patients on antiplatelet drug therapy (Plavix not ASA) has been added to Step 4 - Additional Factors – Age and Co-Morbid Factors.
Due to the decreased platelet aggregation and the inhibiting of thrombus formation, patients appear to be at increased risk of developing life-threatening intracranial hemorrhage.
Base hospital contact is strongly encouraged to help facilitate appropriate destination decisions.
Please ensure all care providers are familiar with this addition.
Please direct any questions regarding this change to:
Joanne Chapman, RN
Trauma/Clinical Coordinator
This email address is being protected from spambots. You need JavaScript enabled to view it.
(707) 321-8665